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TRP mechanism for store-operated Ca2+ 
entry. First, there is no similarity between 
Orai and TRP channels. There is also a 
lack of evidence that Ca2+ store deple-
tion activates TRP channels when intra-
cellular Ca2+ is buffered. Lastly, there is 
no effect on Ca2+ store repletion in mice 
lacking TRPC3 and in triple-knockout 
mice lacking TRPC1, TRPC4, and TRPC6 
(Hartmann et al., 2008).
The two papers address an important 
detail in the mechanism of store-oper-
ated Ca2+ entry and cast doubt on the 
hypothesis that STIM links Orai di mers to 
form active tetrameric channels (Penna 
et al., 2008). The fact that Orai is a self-
contained Ca2+ channel raises the possi-
bility that there are other Orai-activating 
mechanisms. On a practical level, given 
the essential role of CRAC channels 
in T cell activation, it is possible that a 
membrane-permeant peptide (such as 
TAT-CAD) could be a useful means of 
activating T cells, or, conversely, a CAD 
blocking peptide might be used to pre-
vent their activation. If store-operated 
Ca2+ entry proves important in other 
cellular processes, such as apoptosis 
resulting from prolonged ER stress, then 
CAD reagents will find additional uses.
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The serine/threonine kinase Akt is a focal point in signaling pathways that control cell tumorigenesis 
and insulin resistance. In this issue, Padmanabhan et al. (2009) identify a phosphatase regulatory 
subunit PPTR-1 that regulates the insulin/insulin-like growth factor 1 pathway by counteracting 
Akt activity in worms and mammalian cells.The serine/threonine protein kinase 
Akt is a central effector of the insulin/
insulin-like growth factor 1 signaling 
(IIS) pathway that is conserved from 
worm to man. The IIS pathway regu-
lates growth, development, reproduc-
tion, stress responsiveness, and lon-
gevity. Akt is commonly hyperactivated 
in a large number of human cancers, 
often because of activating mutations 
in its key upstream regulator phospho-
inositol 3-kinase (PI3K) or inactivating 
mutations in the opposing lipid phos-
phatase, the tumor suppressor PTEN. 
In contrast to tumorigenesis, loss of 
AKT activity accompanies insulin resis-816 Cell 136, March 6, 2009 ©2009 Elsevier tance in peripheral metabolic tissues in 
diabetic patients, and loss of Akt-2 in 
mice results in a type 2 diabetes-like 
phenotype. Therefore, gaining insight 
into the key positive and negative regu-
latory modules controlling AKT activity 
is central to our basic understanding 
of two common diseases. In this issue, 
Padmanabhan et al. (2009) identify 
the phosphatase regulatory subunit 
PPTR-1 in the worm Caenorhabditis 
elegans, which regulates the IIS path-
way by counteracting Akt activity. This 
regulation controls longevity and has 
implications for the study of cancer and 
diabetes.Inc.Two different phosphorylation events 
are known to be involved in Akt activa-
tion, both of which appear to be depen-
dent on PI3K and are conserved across 
all metazoans (Figure 1). Phosphoryla-
tion of Akt at threonine 308 (Thr350 in 
worm) in the activation loop by the phos-
phoinositide-dependent kinase 1 (PDK1) 
(Figure 1) is absolutely required for Akt 
activity. In contrast, phosphorylation at 
a hydrophobic motif serine site (human 
Ser473/worm Ser517) by the TORC2 
(TOR-rictor) kinase complex is important, 
but appears not to be essential for Akt 
activation in all settings (Polak and Hall, 
2006). In stark contrast to our detailed 
understanding of the circuitry of kinases 
activating Akt, very little is known about 
the counteracting phosphatases.
Padmanabhan et al. performed an RNA 
interference (RNAi)-based screen in C. 
elegans to identify critical phosphatases 
that function within the IIS pathway. Fifty-
seven of the 60 catalytic phosphatase 
genes and six regulatory phosphatase 
subunits were screened for their ability to 
suppress the dauer developmental arrest 
phenotype induced by a temperature-
sensitive allele of daf-2, the sole insulin/
insulin-like growth factor 1 receptor in 
worms. Strikingly, of these 63 genes, 
RNAi directed against only two genes, 
fem-2 and pptr-1, strongly suppresses 
the daf-2 phenotype to the same degree 
as RNAi against daf-18, the homolog of 
PTEN. However, fem-2 RNAi did not sup-
press all daf-2 mutant alleles and was 
not studied further, leaving pptr-1 as the 
focus for additional characterization.
The pptr-1 gene encodes a member 
of the B56 family of regulatory subunits 
for phosphatase 2A (PP2A). RNAi against 
pptr-1 also specifically suppresses the 
extension of life span and fat accumula-
tion observed in IIS pathway mutants, but 
has no effect on a mutant strain deficient 
in transforming growth factor β (TGF-β) 
signaling. RNAi against pptr-1 also sup-
presses transcription that is dependent 
on DAF-16. DAF-16 is a key Akt substrate 
that modulates life span and stress resis-
tance; overexpression of PPTR-1 extends 
life span in a DAF-16 dependent manner. 
Epistasis experiments with multiple com-
ponents of the IIS pathway suggest that 
pptr-1 acts at the level of akt-1, but inter-
estingly does not affect the closely related 
family members akt-2 or sgk-1. Moreover, 
an examination of the expression pattern 
of pptr-1 reveals a distinct overlap with 
akt-1, but not akt-2 or sgk-1. Similarly, the 
PPTR-1 protein coimmunoprecipitates 
with Akt-1 but not Akt-2. An examination 
of the in vivo phosphorylation of Akt-1 in 
worms with phospho-specific antibod-
ies reveals that overexpression of pptr-1 
decreases phosphorylation of the PDK1 
target Thr308, but not phosphorylation of 
the hydrophobic Ser473 site.
Importantly, the investigators provide 
evidence that regulation of Akt Thr308 
dephosphorylation by pptr-1 orthologs 
is conserved in mammalian cells. RNAi 
directed against B56β, one of the five genes encoding B56 regulatory subunits of PP2A 
in mammals, results in Akt hyperphospho-
rylation at Thr308 in insulin-treated adipo-
cytes. These findings are also consistent 
with a recent overexpression screen in the 
fruit fly Drosophila, which reported that 
the closest homolog of pptr-1, widerborst 
(wdb), regulates PI3K/Akt signaling to pro-
mote FOXO activation (Vereshchagina et 
al., 2008). Furthermore, pharmacological 
inhibitors of PP2A, such as okadaic acid, 
have long been known to activate Akt.
figure 1. Akt and Insulin/Insulin-like Growth factor signaling
(A) Wiring of the insulin/insulin-like growth factor signaling pathway in C. elegans and humans. In worms, 
the insulin receptor DAF-2 activates an IRS-1 homolog, IST-1, which activates a phosphoinositide 3-ki-
nase (PI3K) AGE-1. The lipid phosphatidylinositol-3-phosphate (PIP3) generated by PI3K activates the 
two worm Akt homologs, Akt-1 and Akt-2, via their recruitment to the upstream phosphoinositide-de-
pendent kinase 1 (PDK1). PDK1 phosphorylates a key residue in the activation loop of Akt to stimulate 
its kinase activity. Activated Akt then phosphorylates a number of downstream substrates, key among 
them being the conserved forkhead transcription factor DAF-16, resulting in its inactivation by prevent-
ing its translocation to the nucleus. Consistent with these molecules acting together to regulate insulin 
signaling, loss-of-function mutations of daf-2, age-1, pdk-1, akt-1, and akt-2 cause precocious entry into 
diapause, a developmentally arrested larval stage, and increased longevity. Loss-of-function mutations 
of daf-16 completely suppress these phenotypes, indicating that it is a key downstream target of insulin 
signaling controlling longevity in C. elegans.
(B) Regulation of two critical evolutionarily conserved phosphorylation sites in Akt. PDK1 phosphorylates 
threonine 308 (Thr308) in the activation loop of Akt family members, promoting their kinase activity. This site 
is dephosphorylated by PP2A bound to B56 regulatory subunits. The serine 473 (Ser473) hydrophobic motif 
(PDK2) site is phosphorylated by the TORC2 kinase complex composed of TOR and rictor, and this site is 
dephosphorylated by the PHLPP family of phosphatases. Names of gene homologs are provided.Cell 136, March 6, 2009 ©2009 Elsevier Inc. 817
The specificity of pptr-1 and B56 iso-
forms for Akt Thr308 but not Ser473 
dephosphorylation is paralleled by recent 
discoveries of a PHLPP family of conserved 
phosphatases that target Ser473 but not 
Thr308 (Gao et al., 2005). As observed 
here for pptr-1 in worms, different Akt 
family members are targeted by distinct 
PHLPP family members in mammalian 
cells (Brognard et al., 2007). Similarly, one 
might anticipate that multiple mammalian 
B56 isoforms would play a role in regulat-
ing Akt isoforms. Indeed, B56γ and B56β 
have previously been shown to modulate 
Akt signaling in different contexts (Chen et 
al. 2005; Rocher et al., 2007).
Notably, B56 and PHLPP isoforms are 
implicated in cancer and diabetes. B56γ 
is inactivated by SV40 small T antigen in 
cellular transformation (Chen et al., 2004), 
and B56γ is also downregulated in some 
tumors. Somatic mutations that result in 
loss of B56 binding have been reported in 
A subunits of PP2A, and the resulting hap-
loinsufficiency promotes cancer (Wes-
termarck and Hahn, 2008). Conversely, 
the upregulation of PHLPP1 in skeletal 818 Cell 136, March 6, 2009 ©2009 Elsevier
MicroRNAs (miRNAs) are small noncod-
ing RNAs that regulate gene expres-
sion posttranscriptionally. In animals, 
they typically base pair imperfectly with 
sequences in the 3′ untranslated regions 
(3′UTRs) of mRNAs to either inhibit trans-
lation or accelerate mRNA decay. Fol-
lowing excision from longer precursors, 
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cell proliferation and developme
(2009) identify two members of th
regulators of microRNA functionmuscle from diabetic patients correlates 
with the loss of Akt-2 phosphorylation 
at Ser473 (Cozzone et al., 2008). Impor-
tantly, it is unlikely that Akt will be the only 
target of a particular B56 isoform, as p53 
and Wnt signaling are both regulated by 
B56 isoforms. Similarly, protein kinase C 
signaling has been well established as a 
target for PHLPP beyond Akt.
Given the aforementioned complexi-
ties of different phosphatase isoforms 
regulating different Akt family members, 
it is likely that the tissue expression pat-
terns of different mammalian B56 and 
PHLPP isoforms will play a major role in 
dictating the level of responsiveness of 
the PI3K-Akt pathway. Hence, inactiva-
tion of a given isoform of B56 or PHLPP 
might result in a restoration of insulin sig-
naling in metabolic tissues from diabetic 
patients, but could trigger unrestrained 
proliferation in epithelial tissues. Under-
standing the intricacies of Akt regulation 
in different mammalian tissues awaits 
further work, but B56 subunits are now 
clearly front and center in the investiga-
tion of aging and disease. Inc.
miRNAs are loaded into ribonucleopro-
tein particles called miRNPs. Argonaute 
(AGO) and GW182 family proteins, the 
best-characterized components of 
miRNPs, act as key effectors in miRNA 
function. Although as many as 50% of 
all genes might be regulated by the hun-
dreds of miRNAs identified in mammals, 
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